Meenakshi Group to raise up to ₹700 crore for a real estate-focused alternate investment fund
Hyderabad-based real estate firm Meenakshi Group has announced that it will raise up to ₹700 crore for a realty-focused alternative investment fund (AIF), the Meenakshi Real Assets Fund. The company has committed 20% of the corpus size as sponsor capital for the fund, the company said.
The fund, with a total corpus of ₹700 crore (including a ₹350 crore greenshoe option), will follow a hybrid investment strategy by deploying capital across both debt and equity instruments, the company said.
With a six-year investment horizon, the Meenakshi Real Assets Fund will target 6 to 8 high-conviction deals, focusing on self-liquidating real estate assets that offer a combination of steady cash flows and capital appreciation. The fund is geared toward working with Tier I developers operating in high-growth micro-markets across key urban centres, with deal sizes of up to ₹70 crore per transaction, the company said.
Also Read: ASK Property Fund, ISIR-backed real estate AIF raises ₹500 crore for Investment in luxury housing projects
'Securing the AIF license allows us to bring institutional-grade, well-structured investment products to the market. We're already seeing strong early interest, and we have three deals currently under due diligence. We've also received soft commitments from the Meenakshi Group, its wider network, and early investors," Mahesh Katragadda, CEO of Meenakshi Alternates, said.
'Our goal is to build long-term trust and deliver consistent returns by leveraging our strong track record in real estate. We are focused on creating value through disciplined capital deployment and high-quality investment opportunities," he said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
34 minutes ago
- Time of India
Another US-based semicon co to set up project in Bengal
Kolkata: After GlobalFoundries (GF), another US-based semiconductor company — Santech Global Inc — has expressed its interest in setting up a project in Bengal, the state govt said after US Consul General Kathy Giles-Diaz met Bengal CM Mamata Banerjee at Nabanna on Wednesday. Based in New Jersey, Santech Global specialises in semiconductors and nanoelectronics. "We are in consultation with the company to extend required support," an official said. He added that Santech Global setting up a project in Bengal would contribute in the creation of a robust semiconductor ecosystem in the state and open up more economic opportunities. The state govt further said GF has sought additional space to expand operations. The GF project was announced in Sept last year during a meeting between then-US President Joe Biden and Prime Minister Narendra Modi. The CM had earlier stated that necessary land had already been provided to GF — around 13,000 sq ft in the Software Technology Park of India (STPI) at Sector V. GF has asked for another 19,000 sq ft and the CM has assured to look into the request. On Wednesday, the CM and the US Consul discussed the GF Kolkata Power Center, set to come up in collaboration with the US. The CM said the project would be a significant achievement for the state and expressed hope that once in place, it would generate substantial employment. According to an official, the new semiconductor fabrication unit will focus on advanced sensing, communication and power electronics for national security as well as next-generation telecommunications and green energy applications. The official further said GF is a major semiconductor manufacturing company that produces microchips used in electronic devices such as smartphones, computers and cars. He added that GF would also set up a fabless centre for design and testing. Officials said semiconductor units in Bengal would aid research and development in chip manufacturing, and cause major leaps in the fields of Internet of Things, artificial intelligence and data centres.
Mint
an hour ago
- Mint
23andMe Judge Questions Limits for New Auction for Bankrupt Firm
(Bloomberg) -- The judge overseeing the bankruptcy of 23andMe questioned the limits proposed for a second auction that is designed to push bids higher than a current $256 million offer from Regeneron Pharmaceuticals for the genetic-testing firm. US Bankruptcy Judge Brian Walsh asked lawyers for Regeneron and 23andMe to justify the limits they're supporting, but which have been criticized by the only other bidder, a California-based research institute backed by former 23andMe Chief Executive Officer Anne Wojcicki. Walsh has to decide whether to limit the auction in a way that gives Regeneron the chance for a final bid, but not Wojcicki and TTAM Research Institute. The current proposed rules for the auction appear to be 'inefficient,' said Walsh, who also questioned a $10 million breakup fee payable to Regeneron if it loses. All sides were present during a federal court hearing in St. Louis on Wednesday to determine how to revive bidding, after 23andMe held an auction last month that the company initially claimed that Regeneron won with a $256 million final bid. Wojcicki objected after the auction, arguing the bidding was unfairly closed in order to favor Regeneron. The current proposal is 'one-sided with a last look for Regeneron,' Wojcicki's lawyer, Susheel Kirpalani, told Walsh. 'There is absolutely not a level playing field.' Last month's auction lasted three days with each side accusing 23andMe of unfairly favoring their competitor, company bankruptcy attorney Christopher Hopkins said in court. Afterward, TTAM and Wojcicki made a bid that was 'substantially higher' than Regeneron's, he said. 23andMe then proposed a new, final bidding round with the current limits, which Regeneron accepted, but which Wojcicki opposes. Without the limits, Regeneron may cancel its $256 million bid, Hopkins argued. That would mean no more offers would come in allowing TTAM and Wojcicki to get 23andMe for $156 million, since that was their last, binding bid before the auction ended. A wave of customers and government officials have demanded that 23andMe protect the genetic data it had built up over the years by collecting saliva samples from customers. Both bidders have pledged to comply with 23andMe's privacy policy, which allows customers to have their personal information deleted upon request. 23andMe filed for bankruptcy in March after failing to generate sustainable profits by providing medical and ancestry-related genetic testing to more than 15 million customers. About 550,000 people had subscribed to the company's two primary services, which hasn't been enough to keep the company afloat. One of those services, Lemonaid Health, was not part of the sale and will be wound down, 23andMe said in a statement. In the months leading up its bankruptcy, 23andMe tried to attract a buyer while struggling to end a class-action lawsuit related to a 2023 data breach that gave hackers access to customer information. The company will try to resolve those claims as part of the bankruptcy. The case is 23andMe Holding Co., number 25-40976, in the US Bankruptcy Court for the Eastern District of Missouri. --With assistance from Georgia Hall. More stories like this are available on
Economic Times
2 hours ago
- Economic Times
Regulating the regulator
Sebi, governing markets for 3 decades, in search of governance rules for itself A high-level committee appointed by Sebi has started consultations with a wide range of stakeholders to address the conflict-of-interest issues and build a comprehensive framework to manage it. As a new regime takes shape, the challenge will be to improve transparency without getting too onerous. HSBC's next move could shake up India's venture debt play London-based FONT SIZE SAVE PRINT COMMENT Refer & Earn
